PUREMED SYMPRO CAPSULE

Pays: Malaisie

Langue: anglais

Source: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Ingrédients actifs:

FRUCTOOLIGOSACCHARIDES; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS BREVIS; LACTOBACILLUS BULGARICUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS FERMENTUM; LACTOBACILLUS GASSERI; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS PARACASEI SPP. PARACASEI; LACTOBACILLUS SALIVARIUS; LACTOBACILLUS REUTERI; BIFIDOBACTERIUM LACTIS; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM INFANTIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM ANIMALIS; STREPTOCOCCUS THERMOPHILUS; INULIN

Disponible depuis:

Pure Medisciences (M) Sdn Bhd

DCI (Dénomination commune internationale):

FRUCTOOLIGOSACCHARIDES; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS BREVIS; LACTOBACILLUS BULGARICUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS FERMENTUM; LACTOBACILLUS GASSERI; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS PARACASEI SPP. PARACASEI; LACTOBACILLUS SALIVARIUS; LACTOBACILLUS REUTERI; BIFIDOBACTERIUM LACTIS; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM INFANTIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM ANIMALIS; STREPTOCOCCUS THERMOPHILUS; INULIN

Unités en paquet:

20 Capsules; 30 Capsules; 45 Capsules; 60 Capsules; 90 Capsules; 120 Capsules; 135 Capsules; 180 Capsules; 210 Capsules

Fabriqué par:

UAS Laboratories LLC

indications thérapeutiques:

Benefits of Symplus: Multiple strains combination (18 strains). Viable bacterial count, high amount of 30 billion cfu/g. Implement a unique process of commercially producing, freeze-drying and naturally stabilizing the bacterium for delivery to consumers. Introduce non-dairy probiotics. Incorporate the prebiotic (Fructooligasacharides), with probiotics to enhance their growth in intestines.

Descriptif du produit:

Recommended Dosage: Take 1-2 capsules before meal, preferably in the morning.